Drug intelligence / Profile preview

N-[(1S)-5-amino-1-(chloroacetyl)pentyl]-4-methylbenzenesulfonamide

Development stage: Unknown
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules

Overview

N-[(1S)-5-amino-1-(chloroacetyl)pentyl]-4-methylbenzenesulfonamide is an experimental small molecule compound belonging to the class of p-toluenesulfonamides, a subset of sulfonamides. It has been identified as having potential antibacterial properties, likely due to its sulfonamide structure, which is known for interfering with bacterial folic acid synthesis. However, there are no approved indications or clinical trials reported for this compound. Its development status remains experimental and it has not reached any phase of clinical testing or approval in major regulatory jurisdictions[1][6].

Beyond the preview

Go deeper on N-[(1S)-5-amino-1-(chloroacetyl)pentyl]-4-methylbenzenesulfonamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-[(1S)-5-amino-1-(chloroacetyl)pentyl]-4-methylbenzenesulfonamide.

Explore the full profile